Modulation of the Foreign Body Reaction for Implants in the Subcutaneous Space: Microdialysis Probes as Localized Drug Delivery/Sampling Devices
暂无分享,去创建一个
J. Stenken | M. Lennartz | Julie A Stenken | Xiaodun Mou | Michelle R Lennartz | Daniel J Loegering | D. Loegering | X. Mou
[1] P F Morrison,et al. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. , 1990, Life sciences.
[2] Diffusion of [3H]Dexamethasone in Rat Subcutaneous Slices after Injection Measured by Digital Autoradiography , 2006, Biotechnology progress.
[3] P. Vonk,et al. Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers , 1998, Diabetes Care.
[4] S. Amini,et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[5] Francis Moussy,et al. An investigation of long-term performance of minimally invasive glucose biosensors. , 2007, Diabetes technology & therapeutics.
[6] J. B. Justice,et al. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma , 2003, Journal of neurochemistry.
[7] N. Wisniewski,et al. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. , 2001, Journal of biomedical materials research.
[8] P Vadgama. Biosensors in the Body. Continuous In Vivo Monitoring , 1998 .
[9] P. Garris. Advancing neurochemical monitoring , 2010, Nature Methods.
[10] W Kenneth Ward,et al. A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. , 2008, Journal of diabetes science and technology.
[11] J. Stenken,et al. Long-term calibration considerations during subcutaneous microdialysis sampling in mobile rats. , 2010, Biomaterials.
[12] W M Reichert,et al. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. , 2007, Journal of biomedical materials research. Part A.
[13] G. Rao,et al. Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. , 2000, Journal of biomedical materials research.
[14] G. Reach,et al. Continuous glucose monitoring: physiological and technological challenges. , 2008, Current diabetes reviews.
[15] Francis Moussy,et al. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. II. Long-term in vitro/in vivo sensitivity characteristics of sensors with NDGA- or GA-crosslinked collagen scaffolds. , 2010, Journal of biomedical materials research. Part A.
[16] William M Reichert,et al. Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation , 2010, Analytical and bioanalytical chemistry.
[17] S. Woodward. How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensors , 1982, Diabetes Care.
[18] James M. Anderson,et al. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. , 2008, Journal of biomedical materials research. Part A.
[19] G. Coté,et al. Development of a self-cleaning sensor membrane for implantable biosensors. , 2009, Journal of biomedical materials research. Part A.
[20] K. Sakai,et al. An improvement on the method of determining the solute permeability of hollow-fiber dialysis membranes photometrically using optical fibers and comparison of the method with ordinary techniques , 1994 .
[21] J. Santerre,et al. Polycarbonate-urethane hard segment type influences esterase substrate specificity for human-macrophage-mediated biodegradation , 2005, Journal of biomaterials science. Polymer edition.
[22] H. Möllmann,et al. HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids. , 1986, Journal of Pharmaceutical and Biomedical Analysis.
[23] G. Karakiulakis,et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. , 1998, European journal of pharmacology.
[24] B. Sidell,et al. A method for the determination of diffusion coefficients for small molecules in aqueous solution. , 1987, Analytical biochemistry.
[25] K. L. Snyder,et al. Diffusion and calibration properties of microdialysis sampling membranes in biological media. , 2001, The Analyst.
[26] G. S. Wilson,et al. In vivo Electrochemistry: What Can We Learn about Living Systems? , 2008 .
[27] E. M. Renkin,et al. FILTRATION, DIFFUSION, AND MOLECULAR SIEVING THROUGH POROUS CELLULOSE MEMBRANES , 1954, The Journal of general physiology.
[28] N Wisniewski,et al. Characterization of implantable biosensor membrane biofouling , 2000, Fresenius' journal of analytical chemistry.
[29] Kevin H. Hazen,et al. Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels. , 2001, Diabetes technology & therapeutics.
[30] W Kenneth Ward,et al. Controlled release of dexamethasone from subcutaneously-implanted biosensors in pigs: localized anti-inflammatory benefit without systemic effects. , 2010, Journal of biomedical materials research. Part A.
[31] Udo Hoss,et al. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study. , 2010, Diabetes technology & therapeutics.
[32] David D. Cunningham,et al. In Vivo Glucose Sensing , 2009 .
[33] J. Brauker,et al. Continuous glucose sensing: future technology developments. , 2009, Diabetes technology & therapeutics.
[34] K. Wientjes,et al. A model for transport of glucose in adipose tissue to a microdialysis probe. , 2003, Diabetes technology & therapeutics.
[35] F Moussy,et al. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. , 2002, Biomaterials.
[36] M. Schoenfisch,et al. Reducing Implant-Related Infections: Active Release Strategies , 2006 .
[37] R. Andrew Byrd,et al. ASSOCIATION OF BIOMOLECULAR SYSTEMS VIA PULSED FIELD GRADIENT NMR SELF-DIFFUSION MEASUREMENTS , 1995 .
[38] J. Edelman,et al. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. , 2004, Experimental eye research.
[39] J. Bancroft,et al. Theory and Practice of Histological Techniques , 1990 .
[40] Andrés J. García,et al. Chronic inflammatory responses to microgel-based implant coatings. , 2010, Journal of biomedical materials research. Part A.
[41] C. Highley,et al. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. , 2007, Biomaterials.
[42] Fotios Papadimitrakopoulos,et al. Biomaterials/Tissue Interactions: Possible Solutions to Overcome Foreign Body Response , 2010, The AAPS Journal.
[43] U. Ungerstedt,et al. Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. , 2002, American journal of physiology. Endocrinology and metabolism.
[44] W M Reichert,et al. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. , 1998, Journal of biomedical materials research.
[45] U. Ungerstedt,et al. Analyte Flux at a Biomaterial-Tissue Interface over Time: Implications for Sensors for Type 1 and 2 Diabetes Mellitus , 2010, Journal of diabetes science and technology.
[46] K. Jarnagin,et al. Monomeric Monocyte Chemoattractant Protein-1 (MCP-1) Binds and Activates the MCP-1 Receptor CCR2B* , 1998, The Journal of Biological Chemistry.
[47] Pradyot Nandi,et al. Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. , 2009, Analytica chimica acta.
[48] G. S. Wilson,et al. Biosensors for real-time in vivo measurements. , 2005, Biosensors & bioelectronics.
[49] P. Maloney,et al. In vivo and in vitro effects of dexamethasone on leukocyte migration in the rat adjuvant arthritis model , 1982, Inflammation.
[50] N. Gretz,et al. Tissue response to subcutaneous implantation of glucose-oxidase-based glucose sensors in rats. , 2007, Biosensors & bioelectronics.
[51] R. Auerbach,et al. Angiogenesis inhibition: a review. , 1994, Pharmacology & therapeutics.
[52] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.